Troy Hilsenroth is the founder of Biolog-id. Biolog-id has raised $100M in total funding. Backed by Xerys. Based in Paris, France.
Troy L. Hilsenroth is the CEO of Biolog-id, a digital health solution provider. Biolog-id focuses on optimizing value chains for health products, including labile blood products, plasma for fractionation, and chemotherapy injectables. The company was founded in 2005 and has raised over $100 million in total funding, with Xerys Invest being a notable investor.
Full founder directory · Investor directory · Company funding database · Fundraising library